It’s becoming more and more apparent as to why Pfizer tried – albeit unsuccessfully – to withhold their COVID jab trial data for 75 years. Now, with the release of the data, internet sleuths are uncovering problems suggestive of fraud and manipulation, including the suspicious site 4444. Story at-a-glance In November 2021, Brook Jackson, a whistleblower who worked on Pfizer’s Phase 3 COVID jab trial in the fall of 2020, warned she’d seen evidence of fraud in the trial
With the release of Pfizer trial data — which they tried to withhold for 75 years — additional problems suggestive of fraud and data manipulation are coming to light
Trial site 1231, located in Argentina, somehow managed to recruit 10% of the total trial participants, 4,501 in all, and they did so in just three weeks, and without a contract research organization — a feat that has many questioning whether fraud was committed
The lead investigator for trial site 1231 is Dr. Fernando Polack, who also happens to be a consultant for the U.S. Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee (RBPAC), a current adjunct professor at Vanderbilt University in Tennessee, an investigator for Fundación Infant, funded by the Bill & Melinda Gates foundation, and the first author of Pfizer’s paper, “Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine,” published at the end of December 2021
Site 1231 held a second enrollment session, given the designation of “site 4444.” The 4444 trial site data raise another red flag. It supposedly enrolled 1,275 patients in a single week, from September 22 through 27, 2020 — the last week that recruitment could take place to meet the data cutoff for the FDA meeting in December 2020. Was “site 4444” fabricating data to create the appearance that the jab was having an effect? In November 2021, Brook Jackson, a whistleblower who worked on Pfizer’s Phase 3 COVID jab trial in the fall of 2020, warned she’d seen evidence of fraud in the trial.
…